Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Kidney and Transplant

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 1 · 50%Moderate 0 · 0%High 0 · 0%

Number reaching target Hb · anaemia in predialysis patients

Epoetin alpha every 2 weeks may leads to lower number reaching target Hb compared with to weekly (low certainty).

1 finding from 1 review

Short‐acting erythropoiesis‐stimulating agents for anaemia in predialysis patients 2017 · Cochrane Headline outcomes only
RR 0.96 [0.93, 0.99]
4 studies · 798 participants
Low

Number reaching target Hb · anaemia in predialysis patients

It is very uncertain whether epoetin alfa every four weeks changes number reaching target Hb compared with with every two weeks (very low certainty).

1 finding from 1 review

Short‐acting erythropoiesis‐stimulating agents for anaemia in predialysis patients 2017 · Cochrane Headline outcomes only
RR 0.95 [0.84, 1.07]
3 studies · 687 participants
Very low